symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
NMRD,0.275,0.379536,217245,7947335,0,0.25-3.43,0.0148,Nemaura Medical Inc.,USD,0001602078,US6404422080,640442208,NASDAQ Capital Market,NASDAQ,Medical Devices,https://nemauramedical.com,"Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.",Dr. Dewan Fazlul Hoque Chowdhury Ph.D.,Healthcare,US,36,646 416 7912,57 West 57th Street,New York,NY,10019,1.75001,3.40001,https://financialmodelingprep.com/image-stock/NMRD.png,2018-02-05,False,False,True,False,False
